Mycophenolic Acid Accord Healthcare

Mycophenolic Acid, the active ingredient in Mycophenolic Acid Accord Healthcare, is an immunosuppressant presented as an oral formulation for oral use. It is used to prevent acute organ transplant rejection and to maintain graft survival in transplant recipients.

GNH USA supplies Mycophenolic Acid Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Mycophenolic Acid is an immunosuppressant that acts on lymphocyte proliferation to protect transplanted organs. - Kidney transplant: prevents acute rejection and supports long‑term graft function. - Heart transplant: reduces the risk of early rejection episodes. - Liver transplant: helps maintain graft viability and reduces rejection rates. - Maintenance therapy: sustains graft health after the initial post‑operative period.

Adverse reactions may occur with mycophenolic acid therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools. - Vomiting: occasional emesis. - Abdominal pain: cramping or discomfort. - Headache: transient mild headache. - Infections: increased susceptibility to common infections.

Serious or Rare Side Effects: - Leukopenia: significant reduction in white blood cells. - Anemia: decreased red blood cell count. - Severe infections: opportunistic or life‑threatening infections. - Malignancy: increased risk of certain cancers. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Progressive multifocal leukoencephalopathy (PML): rare demyelinating disease.

Patients receiving mycophenolic acid should be monitored closely for safety. - Monitor blood counts: regular CBC to detect leukopenia or anemia. - Monitor renal function: assess creatinine and eGFR periodically. - Avoid use in uncontrolled infection: defer therapy until infection is treated. - Adjust dose in hepatic impairment: consider reduced dosing if liver function is compromised. - Counsel on contraception: advise effective birth control due to unknown pregnancy safety. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mycophenolic acid can interact with several medicines; some require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Azathioprine: additive bone‑marrow suppression. - Cyclosporine: increased mycophenolic acid exposure. - Tacrolimus: heightened immunosuppressive effect. - Live vaccines: risk of severe infection. - Cholestyramine: reduces oral absorption.

Moderate Interactions (Monitor Closely): - Antacids (aluminum or magnesium): may lower absorption. - NSAIDs: potential for renal impairment. - Warfarin: may alter anticoagulant effect. - Ribavirin: increased hematologic toxicity. - Fluconazole: modest increase in mycophenolic acid levels.